| 000 | 01646 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250513141455.0 | ||
| 264 | 0 | _c19980501 | |
| 008 | 199805s 0 0 eng d | ||
| 022 | _a0022-2623 | ||
| 024 | 7 |
_a10.1021/jm980053f _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPatane, M A | |
| 245 | 0 | 0 |
_a4-Amino-2-[4-[1-(benzyloxycarbonyl)-2(S)- [[(1,1-dimethylethyl)amino]carbonyl]-piperazinyl]-6, 7-dimethoxyquinazoline (L-765,314): a potent and selective alpha1b adrenergic receptor antagonist. _h[electronic resource] |
| 260 |
_bJournal of medicinal chemistry _cApr 1998 |
||
| 300 |
_a1205-8 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAdrenergic alpha-1 Receptor Antagonists |
| 650 | 0 | 4 |
_aAdrenergic alpha-Antagonists _xchemical synthesis |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntihypertensive Agents _xchemical synthesis |
| 650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aOrgan Specificity |
| 650 | 0 | 4 |
_aPrazosin _xanalogs & derivatives |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Inbred SHR |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aReceptors, Adrenergic, alpha-1 _xmetabolism |
| 650 | 0 | 4 |
_aSpinal Cord _xmetabolism |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 700 | 1 | _aScott, A L | |
| 700 | 1 | _aBroten, T P | |
| 700 | 1 | _aChang, R S | |
| 700 | 1 | _aRansom, R W | |
| 700 | 1 | _aDiSalvo, J | |
| 700 | 1 | _aForray, C | |
| 700 | 1 | _aBock, M G | |
| 773 | 0 |
_tJournal of medicinal chemistry _gvol. 41 _gno. 8 _gp. 1205-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1021/jm980053f _zAvailable from publisher's website |
| 999 |
_c9516253 _d9516253 |
||